PhaseV Advances Machine Learning-Driven Lupus Research in New Toronto Collaboration
PhaseV, a leader in software and machine learning (ML) for advanced clinical development optimization, today announced it has ...
manilatimes52m
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated ...
DigitalOcean rises as Morgan Stanley ups to Overweight on AI prospects
DigitalOcean (NYSE:DOCN) was in the spotlight on Thursday as Morgan Stanley upgraded the cloud service provider, citing the ...
emjreviews.com50m
Adverse Events During Transitions of Care from the Emergency Department to the Inpatient Setting
Medical and public health professionals are acutely aware of the significant public health concerns posed by adverse events ...